AGHeadlines: October 2025 – Innovations in Women’s Health
- Hannah Hunt
- Nov 6
- 2 min read
Welcome to the October 2025 edition of AGHeadlines, providing you with insight every quarter on the latest technologies and tools in women's health helping clinicians deliver exceptional care for women in the UK.
In This Edition
WID-easy NHS Pilots Underway
A 650-patient pilot study of the WID-easy® test for endometrial cancer has begun at University of Sussex NHS Trust. The pilot involves women experiencing post-menopausal bleeding across Worthing, St Richard’s, and Southlands Hospitals.
This marks a major milestone toward transforming diagnostic pathways for women at risk of endometrial cancer. Two additional pilots are expected to launch at major London Trusts before 2026, further strengthening the evidence base for this simple, accurate molecular test.
UK Launch: NeoBellyBand™
We’re excited to introduce the NeoBellyBand™ (NBB) to the UK - an innovative device designed to support the abdominal muscles of infants experiencing abdominal wall weakness, distension, or gaseous distension, particularly those on CPAP.
By stabilising the abdominal wall, NeoBellyBand™ supports optimal cardiopulmonary, gastrointestinal, and musculoskeletal function in neonates. It’s a simple, evidence-based solution that’s easy to apply and provides immediate support where it’s needed most.
DILAPAN-S at QE Gateshead: Watch the Story
Hear directly from Jill Sturt, consultant obstetrician and gynaecologist, and Claire Cameron, Matron for Acute Midwifery Services at QE Gateshead, as she shares the Trust’s journey implementing DILAPAN-S.
The video explores:
Implementing DILAPAN-S in a large NHS unit
Comparing outcomes with pharmacological induction methods
Staff training and patient feedback
Lessons learned for successful adoption
“I have to say, my final findings really surprised me — I’ve completely converted to DILAPAN-S.”— Claire Cameron, QE Gateshead
Upcoming Events
Virtual Training: DILAPAN-S🗓 November 28th @ 12:00pm
Join our upcoming webinar to get certified to use DILAPAN-S.
Virtual Training: AmniSure 🗓 December 12th @ 12:00pm
Join our upcoming webinar to get certified to use AmniSure.
Supporting the National Maternity Review
With 14 NHS Trusts currently under investigation, the focus on maternity and neonatal service improvement has never been greater. At AGHealth, we partner with maternity teams nationwide to deliver clinical excellence, efficiency, and safer care through evidence-based products and implementation support.
Our Key Solutions
AmniSure: The only point-of-care PROM test that compares to the gold standard.
PartoSure: Accurate assessment to identify those truly at risk of preterm labour.
Lumella: Rapid, reliable point-of-care test for preeclampsia.
DILAPAN-S: Effective, non-pharma induction of labour with high maternal satisfaction.
📅 Book a call with your account manager to discuss how we can support your maternity unit.
